217 related articles for article (PubMed ID: 7550556)
21. Drug interactions with hormonal contraception.
Guillebaud J
J Fam Plann Reprod Health Care; 2005 Oct; 31(4):335-6; author reply 336. PubMed ID: 16274570
[No Abstract] [Full Text] [Related]
22. [Estrogen-progestin contraception. Disadvantages of estrogen reduction].
Denis C
Contracept Fertil Sex; 1993 Jun; 21(6):481-8. PubMed ID: 7920935
[TBL] [Abstract][Full Text] [Related]
23. [How to choose a contraceptive pill that suits?].
Kivijärvi A
Duodecim; 1997; 113(12):1169-73. PubMed ID: 11466847
[No Abstract] [Full Text] [Related]
24. [Contraception. Method, efficacy, choice, contra-indications, monitoring, risk].
Mensier A; Lopes P
Rev Prat; 1996 Jan; 46(1):119-28. PubMed ID: 8596885
[No Abstract] [Full Text] [Related]
25. [Risks and benefits of hormonal contraception].
Lähteenmäki P
Duodecim; 1987; 103(9):525-31. PubMed ID: 3331140
[No Abstract] [Full Text] [Related]
26. Clinical experiences with birth control in Poland.
Sternadel Z
Mater Med Pol; 1976; 8(4):456-8. PubMed ID: 1027963
[No Abstract] [Full Text] [Related]
27. [Basic principles of hormonal contraception].
Birkhäuser M
Ther Umsch; 2009 Feb; 66(2):67-9. PubMed ID: 19274855
[No Abstract] [Full Text] [Related]
28. [Continuous use--the important trend of combined hormonal contraception].
Cibula D
Ceska Gynekol; 2006 Jan; 71(1):66-9. PubMed ID: 16465919
[TBL] [Abstract][Full Text] [Related]
29. [Estroprogestational minipills: breast diseases and functional cysts of the ovary. Apropos of 87 cases].
Vincens M; de Lignières B; Gompel A
Therapie; 1985; 40(3):177-80. PubMed ID: 4012662
[No Abstract] [Full Text] [Related]
30. Population Reports. Lower-dose pills.
Popul Rep A; 1988 Nov; (7):1-31. PubMed ID: 3076873
[No Abstract] [Full Text] [Related]
31. Cardiovascular disease and steroid hormone contraception. Report of a WHO Scientific Group.
World Health Organ Tech Rep Ser; 1998; 877():i-vii, 1-89. PubMed ID: 9615606
[TBL] [Abstract][Full Text] [Related]
32. [Effects of hormonal contraception on benign changes of the breast].
De Cecco L; Ragni N; Boccardo E; Viglino S
Minerva Ginecol; 1982 Nov; 34(11):889-94. PubMed ID: 6818496
[No Abstract] [Full Text] [Related]
33. Genital cancer and oral contraceptives. The good news!
Skouby SO
Eur J Contracept Reprod Health Care; 2008 Dec; 13(4):327-9. PubMed ID: 19117249
[No Abstract] [Full Text] [Related]
34. Oral contraceptive formulation and ovarian cysts: FDA committee finds no increased risk of follicular enlargement with low-dose monophasic or triphasic preparations.
Contracept Rep; 1994 Mar; 5(1):6-9. PubMed ID: 12287739
[TBL] [Abstract][Full Text] [Related]
35. Menstrual suppression: benefits and risks of continuous combined oral contraceptives.
Dougherty PL
Nurs Womens Health; 2008 Jun; 12(3):243-8. PubMed ID: 18557855
[No Abstract] [Full Text] [Related]
36. The Effects of Hormonal Contraception on the Voice: History of Its Evolution in the Literature.
Rodney JP; Sataloff RT
J Voice; 2016 Nov; 30(6):726-730. PubMed ID: 26602418
[TBL] [Abstract][Full Text] [Related]
37. Ovarian cysts and hormonal contraception.
Ylikorkala O
Lancet; 1977 May; 1(8021):1101-2. PubMed ID: 68197
[No Abstract] [Full Text] [Related]
38. Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk.
Maxwell GL; Schildkraut JM; Calingaert B; Risinger JI; Dainty L; Marchbanks PA; Berchuck A; Barrett JC; Rodriguez GC
Gynecol Oncol; 2006 Nov; 103(2):535-40. PubMed ID: 16740300
[TBL] [Abstract][Full Text] [Related]
39. Contraceptive for obese women: considerations.
Kelsey B
Nurse Pract; 2010 Mar; 35(3):24-31; quiz 31-2. PubMed ID: 20164732
[No Abstract] [Full Text] [Related]
40. [Treatment with oral contraceptives. Swiss consensus conference on frequently discussed questions about hormonal contraception].
Strobel E
Fortschr Med; 1992 Jul; 110(20):369-70. PubMed ID: 1521840
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
